Shares of Arm Holdings surged nearly 7% after CEO Rene Haas told CNBC's Jim Cramer on September 16 that his confidence in hitting $2 billion in revenue from the company's new data-center processor has grown yet again — the third straight escalation since May. Haas said: "I'm more confident today than I was on that July earnings." For investors, the question is no longer whether customers want the chip. It's whether Arm can actually build enough of them.
- Demand Doubled in Eight Weeks — Then the Factory Floor Became the Problem. Demand for Arm's AI-focused data-center chip surged from $1 billion in March 2026 to over $2 billion by May — a doubling in roughly eight weeks.
But the stock fell 10% after Arm kept its official $1 billion revenue outlook because it hadn't secured enough manufacturing capacity to fill the extra orders.
Haas described the market as "very, very tight" across memory, test equipment, substrates, and TSMC wafers — the specialized silicon foundry that makes the chips.
- Arm Is Pivoting From Licensing Blueprints to Selling Actual Chips. For decades, Arm's model was to design processor architectures, license them to other companies, and collect royalties. The new AI chip represents a meaningful departure from that playbook.
Haas claimed "data center is going to be our largest business" — a pivot that changes customer concentration, deal size, and profit trajectory for a company historically built on smartphone royalties. Initial gross margins in the low 40% range will dilute profitability versus the near-pure-profit licensing business.
- The Numbers Back Up the Hype — Mostly. Quarterly revenue for the three months ending June 2026 reached $1.289 billion, up from $1.053 billion a year earlier.
Royalty revenue climbed 22% to $715 million, with data-center royalties more than doubling again. But GAAP earnings per share of $0.25 missed the $0.40 consensus as R&D spending climbed to $838 million — the cost of building a chip business from scratch.
- The Stock Prices In a Lot of Good News. ARM trades at 247 times trailing earnings, up 123% year-to-date.
Shares remain roughly 45% below their June high of $452 following a parabolic run in the first half of the year.
Analyst sentiment leans heavily bullish, with 27 buy or strong-buy ratings against just two sells. The risk: if supply bottlenecks delay revenue into fiscal 2029, today's valuation leaves little room for disappointment.